Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 622

1.

Severity of coeliac disease and clinical management study when using a CYP3A4 metabolised medication: a phase I pharmacokinetic study.

Chretien ML, Bailey DG, Asher L, Parfitt J, Driman D, Gregor J, Dresser GK.

BMJ Open. 2020 Mar 4;10(3):e034086. doi: 10.1136/bmjopen-2019-034086.

2.

Theophylline adenosine dipyridamole (CTAD) and citrate evaluation to survey unfractionated heparin treatment: a delayed centrifugation validation for anti-Xa measurement?

Billoir P, Clavier T, Guilbert A, Barbay V, Chrétien MH, Fresel M, Abriou C, Girault C, Le Cam Duchez V.

Ann Biol Clin (Paris). 2020 Feb 1;78(1):27-34. doi: 10.1684/abc.2020.1525.

PMID:
32108577
3.

The enigma of soluble LDLR: could inflammation be the key?

Mbikay M, Mayne J, Chrétien M.

Lipids Health Dis. 2020 Feb 3;19(1):17. doi: 10.1186/s12944-020-1199-9.

4.

B-ALL With t(5;14)(q31;q32); IGH-IL3 Rearrangement and Eosinophilia: A Comprehensive Analysis of a Peculiar IGH-Rearranged B-ALL.

Fournier B, Balducci E, Duployez N, Clappier E, Cuccuini W, Arfeuille C, Caye-Eude A, Delabesse E, Bottollier-Lemallaz Colomb E, Nebral K, Chrétien ML, Derrieux C, Cabannes-Hamy A, Dumezy F, Etancelin P, Fenneteau O, Frayfer J, Gourmel A, Loosveld M, Michel G, Nadal N, Penther D, Tigaud I, Fournier E, Reismüller B, Attarbaschi A, Lafage-Pochitaloff M, Baruchel A.

Front Oncol. 2019 Dec 10;9:1374. doi: 10.3389/fonc.2019.01374. eCollection 2019.

5.

[Bloody tears: About a case and a review of the literature].

Billoir P, Feugray G, Chrétien MH 5th, Fresel M, Le Cam Duchez V.

Rev Med Interne. 2019 Dec 24. pii: S0248-8663(19)31183-X. doi: 10.1016/j.revmed.2019.12.007. [Epub ahead of print] French.

PMID:
31882188
6.

BAM conditioning before autologous transplantation for lymphoma: a study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC).

Cornillon J, Daguenet E, Bay JO, Chauchet A, Salles G, Contentin N, Nicolas-Virelizier E, Mercier M, Vallet N, Alexis M, Chrétien ML, Cluzeau T, Huynh A, Himberlin C, Dorvaux V, Amorim S, Lejeune C, de Latour RP, Gyan E.

Ann Hematol. 2019 Aug;98(8):1973-1980. doi: 10.1007/s00277-019-03704-z. Epub 2019 May 20.

PMID:
31111177
7.

Is citrate theophylline adenosine dipyridamole (CTAD) better than citrate to survey unfractionated heparin treatment? Has delayed centrifugation a real impact on this survey?

Billoir P, Clavier T, Guilbert A, Barbay V, Chrétien MH, Fresel M, Abriou C, Girault C, Le Cam Duchez V.

J Thromb Thrombolysis. 2019 Aug;48(2):277-283. doi: 10.1007/s11239-019-01882-1.

PMID:
31098816
8.

Development and Validation of a Cytogenetic Prognostic Index Predicting Survival in Multiple Myeloma.

Perrot A, Lauwers-Cances V, Tournay E, Hulin C, Chretien ML, Royer B, Dib M, Decaux O, Jaccard A, Belhadj K, Brechignac S, Fontan J, Voillat L, Demarquette H, Collet P, Rodon P, Sohn C, Lifermann F, Orsini-Piocelle F, Richez V, Mohty M, Macro M, Minvielle S, Moreau P, Leleu X, Facon T, Attal M, Avet-Loiseau H, Corre J.

J Clin Oncol. 2019 Jul 1;37(19):1657-1665. doi: 10.1200/JCO.18.00776. Epub 2019 May 15.

9.

Effectiveness of a 6-Week Day Hospital Treatment for Personality Disorders: Data From a Naturalistic Study.

Savard C, Chrétien M, Gamache D, Maranda J, Villeneuve E.

J Psychiatr Pract. 2019 May;25(3):199-205. doi: 10.1097/PRA.0000000000000382.

PMID:
31083032
10.

Carfilzomib Weekly plus Melphalan and Prednisone in Newly Diagnosed Transplant-Ineligible Multiple Myeloma (IFM 2012-03): A Phase I Trial.

Leleu X, Fouquet G, Richez V, Guidez S, Duhamel A, Machuron F, Karlin L, Kolb B, Tiab M, Araujo C, Meuleman N, Malfuson JV, Bourquard P, Lenain P, Roussel M, Jaccard A, Pétillon MO, Belhadj-Merzoug K, Lepeu G, Chrétien ML, Fontan J, Rodon P, Schmitt A, Offner F, Voillat L, Cereja S, Kuhnowski F, Rigaudeau S, Decaux O, Humbrecht-Kraut C, Frayfer J, Fitoussi O, Roos-Weil D, Eisenmann JC, Dorvaux V, Voog EG, Attal M, Moreau P, Avet-Loiseau H, Hulin C, Facon T.

Clin Cancer Res. 2019 Jul 15;25(14):4224-4230. doi: 10.1158/1078-0432.CCR-18-3642. Epub 2019 May 3.

PMID:
31053600
11.

Adherence to immunomodulatory drugs in patients with multiple myeloma.

Cransac A, Aho S, Chretien ML, Giroud M, Caillot D, Boulin M.

PLoS One. 2019 Mar 27;14(3):e0214446. doi: 10.1371/journal.pone.0214446. eCollection 2019.

12.

Thrombin generation profile in non-thrombotic factor V Leiden carriers.

Billoir P, Duflot T, Fresel M, Chrétien MH, Barbay V, Le Cam Duchez V.

J Thromb Thrombolysis. 2019 Apr;47(3):473-477. doi: 10.1007/s11239-019-01821-0.

PMID:
30701464
13.

First case of proven invasive pulmonary infection due to Trichoderma longibrachiatum in a neutropenic patient with acute leukemia.

Sautour M, Chrétien ML, Valot S, Lafon I, Basmaciyan L, Legouge C, Verrier T, Gonssaud B, Abou-Hanna H, Dalle F, Caillot D.

J Mycol Med. 2018 Dec;28(4):659-662. doi: 10.1016/j.mycmed.2018.10.001. Epub 2018 Oct 26.

PMID:
30477694
14.

Anti-Xa Oral Anticoagulant Plasma Concentration Assay in Real Life: Rivaroxaban and Apixaban Quantification in Emergency With LMWH Calibrator.

Billoir P, Barbay V, Joly LM, Fresel M, Chrétien MH, Le Cam Duchez V.

Ann Pharmacother. 2019 Apr;53(4):341-347. doi: 10.1177/1060028018811657. Epub 2018 Oct 31.

PMID:
30378443
15.

Myeloma MRD by deep sequencing from circulating tumor DNA does not correlate with results obtained in the bone marrow.

Mazzotti C, Buisson L, Maheo S, Perrot A, Chretien ML, Leleu X, Hulin C, Manier S, Hébraud B, Roussel M, Do Souto L, Attal M, Avet-Loiseau H, Corre J.

Blood Adv. 2018 Nov 13;2(21):2811-2813. doi: 10.1182/bloodadvances.2018025197. No abstract available.

16.

Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma.

Perrot A, Lauwers-Cances V, Corre J, Robillard N, Hulin C, Chretien ML, Dejoie T, Maheo S, Stoppa AM, Pegourie B, Karlin L, Garderet L, Arnulf B, Doyen C, Meuleman N, Royer B, Eveillard JR, Benboubker L, Dib M, Decaux O, Jaccard A, Belhadj K, Brechignac S, Kolb B, Fohrer C, Mohty M, Macro M, Richardson PG, Carlton V, Moorhead M, Willis T, Faham M, Anderson KC, Harousseau JL, Leleu X, Facon T, Moreau P, Attal M, Avet-Loiseau H, Munshi N.

Blood. 2018 Dec 6;132(23):2456-2464. doi: 10.1182/blood-2018-06-858613. Epub 2018 Sep 24.

17.

Ponatinib evaluation and safety in real-life chronic myelogenous leukemia patients failing more than two tyrosine kinase inhibitors: the PEARL observational study.

Heiblig M, Rea D, Chrétien ML, Charbonnier A, Rousselot P, Coiteux V, Escoffre-Barbe M, Dubruille V, Huguet F, Cayssials E, Hermet E, Guerci-Bresler A, Amé S, Sackmann-Sala L, Roy L, Sobh M, Morisset S, Etienne G, Nicolini FE.

Exp Hematol. 2018 Nov;67:41-48. doi: 10.1016/j.exphem.2018.08.006. Epub 2018 Sep 5.

PMID:
30195076
18.

Management of dabigatran after overdosage: two case reports and suggestions for monitoring.

Billoir P, Girault C, Barbay V, Boyer D, Grangé S, Fresel M, Chrétien MH, Le Cam Duchez V.

Blood Coagul Fibrinolysis. 2018 Nov;29(7):653-655. doi: 10.1097/MBC.0000000000000763.

PMID:
30045050
19.

Associations Between Soluble LDLR and Lipoproteins in a White Cohort and the Effect of PCSK9 Loss-of-Function.

Mayne J, Ooi TC, Tepliakova L, Seebun D, Walker K, Mohottalage D, Ning Z, Abujrad H, Mbikay M, Wassef H, Chrétien M, Figeys D.

J Clin Endocrinol Metab. 2018 Sep 1;103(9):3486-3495. doi: 10.1210/jc.2018-00777.

PMID:
29982529
20.

[Retrospective study of 25 cases of pulmonary mucormycosis in acute leukaemia].

Caillot D, Legouge C, Lafon I, Ferrant E, Pagès PB, Plocque A, Estivalet L, Valot S, Dalle F, Abou Hanna H, Chretien ML.

Rev Mal Respir. 2018 Apr;35(4):452-464. doi: 10.1016/j.rmr.2017.11.009. Epub 2018 May 10. Review. French.

PMID:
29754839
21.

HSP27 is a partner of JAK2-STAT5 and a potential therapeutic target in myelofibrosis.

Sevin M, Kubovcakova L, Pernet N, Causse S, Vitte F, Villeval JL, Lacout C, Cordonnier M, Rodrigues-Lima F, Chanteloup G, Mosca M, Chrétien ML, Bastie JN, Audia S, Sagot P, Ramla S, Martin L, Gleave M, Mezger V, Skoda R, Plo I, Garrido C, Girodon F, de Thonel A.

Nat Commun. 2018 Apr 12;9(1):1431. doi: 10.1038/s41467-018-03627-9.

22.

Antibody-Drug Conjugates for the Treatment of Hematological Malignancies: A Comprehensive Review.

Rossi C, Chrétien ML, Casasnovas RO.

Target Oncol. 2018 Jun;13(3):287-308. doi: 10.1007/s11523-018-0558-1. Review.

PMID:
29556925
23.

Dysregulated IL-18 Is a Key Driver of Immunosuppression and a Possible Therapeutic Target in the Multiple Myeloma Microenvironment.

Nakamura K, Kassem S, Cleynen A, Chrétien ML, Guillerey C, Putz EM, Bald T, Förster I, Vuckovic S, Hill GR, Masters SL, Chesi M, Bergsagel PL, Avet-Loiseau H, Martinet L, Smyth MJ.

Cancer Cell. 2018 Apr 9;33(4):634-648.e5. doi: 10.1016/j.ccell.2018.02.007.

24.

Extending autologous transplantation as first line therapy in multiple myeloma patients with severe renal impairment: a retrospective study by the SFGM-TC.

Augeul-Meunier K, Chretien ML, Stoppa AM, Karlin L, Benboubker L, Diaz JMT, Mohty M, Yakoub-Agha I, Bay JO, Perrot A, Bulabois CE, Huynh A, Mercier M, Frenzel L, Avet-Loiseau H, de Latour RP, Cornillon J.

Bone Marrow Transplant. 2018 Jun;53(6):749-755. doi: 10.1038/s41409-018-0122-8. Epub 2018 Mar 9.

PMID:
29523884
25.

Malaria severity: Possible influence of the E670G PCSK9 polymorphism: A preliminary case-control study in Malian children.

Arama C, Diarra I, Kouriba B, Sirois F, Fedoryak O, Thera MA, Coulibaly D, Lyke KE, Plowe CV, Chrétien M, Doumbo OK, Mbikay M.

PLoS One. 2018 Feb 15;13(2):e0192850. doi: 10.1371/journal.pone.0192850. eCollection 2018.

26.

Mice Fed a High-Cholesterol Diet Supplemented with Quercetin-3-Glucoside Show Attenuated Hyperlipidemia and Hyperinsulinemia Associated with Differential Regulation of PCSK9 and LDLR in their Liver and Pancreas.

Mbikay M, Mayne J, Sirois F, Fedoryak O, Raymond A, Noad J, Chrétien M.

Mol Nutr Food Res. 2018 May;62(9):e1700729. doi: 10.1002/mnfr.201700729. Epub 2018 Apr 23.

PMID:
29396908
27.

Efficacy, safety, and cost of pomalidomide in relapsed and refractory multiple myeloma.

Gueneau P, Chretien ML, Cransac-Miet A, Aho LS, Lafon I, Favennec C, Guy J, Caillot D, Boulin M.

Eur J Haematol. 2018 May;100(5):518-525. doi: 10.1111/ejh.13039. Epub 2018 Mar 6.

PMID:
29393533
28.

The ever-expanding saga of the proprotein convertases and their roles in body homeostasis: emphasis on novel proprotein convertase subtilisin kexin number 9 functions and regulation.

Seidah NG, Chrétien M, Mbikay M.

Curr Opin Lipidol. 2018 Apr;29(2):144-150. doi: 10.1097/MOL.0000000000000484. Review.

PMID:
29342010
29.

Expressed fusion gene landscape and its impact in multiple myeloma.

Cleynen A, Szalat R, Kemal Samur M, Robiou du Pont S, Buisson L, Boyle E, Chretien ML, Anderson K, Minvielle S, Moreau P, Attal M, Parmigiani G, Corre J, Munshi N, Avet-Loiseau H.

Nat Commun. 2017 Dec 1;8(1):1893. doi: 10.1038/s41467-017-00638-w.

30.

Antiviral activity of quercetin-3-β-O-D-glucoside against Zika virus infection.

Wong G, He S, Siragam V, Bi Y, Mbikay M, Chretien M, Qiu X.

Virol Sin. 2017 Dec;32(6):545-547. doi: 10.1007/s12250-017-4057-9.

31.

Cognitive restructuring of gambling-related thoughts: A systematic review.

Chrétien M, Giroux I, Goulet A, Jacques C, Bouchard S.

Addict Behav. 2017 Dec;75:108-121. doi: 10.1016/j.addbeh.2017.07.001. Epub 2017 Jul 8. Review.

PMID:
28728039
32.

The Effect of PCSK9 Loss-of-Function Variants on the Postprandial Lipid and ApoB-Lipoprotein Response.

Ooi TC, Krysa JA, Chaker S, Abujrad H, Mayne J, Henry K, Cousins M, Raymond A, Favreau C, Taljaard M, Chrétien M, Mbikay M, Proctor SD, Vine DF.

J Clin Endocrinol Metab. 2017 Sep 1;102(9):3452-3460. doi: 10.1210/jc.2017-00684.

PMID:
28673045
33.

Validation of response assessment according to international consortium for MDS/MPN criteria in chronic myelomonocytic leukemia treated with hypomethylating agents.

Duchmann M, Braun T, Micol JB, Platzbecker U, Park S, Pilorge S, Beyne-Rauzy O, Vey N, Sébert M, Gruson B, Dumas PY, Guieze R, Chretien ML, Laribi K, Chait Y, Legros L, Sahnes L, Hirsch P, Salanoubat C, Solary E, Fenaux P, Itzykson R.

Blood Cancer J. 2017 May 12;7(5):e562. doi: 10.1038/bcj.2017.41. No abstract available.

34.

Using Virtual Reality in the Treatment of Gambling Disorder: The Development of a New Tool for Cognitive Behavior Therapy.

Bouchard S, Robillard G, Giroux I, Jacques C, Loranger C, St-Pierre M, Chrétien M, Goulet A.

Front Psychiatry. 2017 Feb 24;8:27. doi: 10.3389/fpsyt.2017.00027. eCollection 2017.

35.

Is It Time to Include CT "Reverse Halo Sign" and qPCR Targeting Mucorales in Serum to EORTC-MSG Criteria for the Diagnosis of Pulmonary Mucormycosis in Leukemia Patients?

Caillot D, Valot S, Lafon I, Basmaciyan L, Chretien ML, Sautour M, Million L, Legouge C, Payssot A, Dalle F.

Open Forum Infect Dis. 2016 Nov 8;3(4):ofw190. doi: 10.1093/ofid/ofw190. eCollection 2016 Oct. Erratum in: Open Forum Infect Dis. 2017 Jun 29;4(2):ofx025.

36.

Nosocomial Infections with IMP-19-Producing Pseudomonas aeruginosa Linked to Contaminated Sinks, France.

Amoureux L, Riedweg K, Chapuis A, Bador J, Siebor E, Péchinot A, Chrétien ML, de Curraize C, Neuwirth C.

Emerg Infect Dis. 2017 Feb;23(2):304-307. doi: 10.3201/eid2302.160649.

37.

Comparing expression and activity of PCSK9 in SPRET/EiJ and C57BL/6J mouse strains shows lack of correlation with plasma cholesterol.

Sirois F, Chrétien M, Mbikay M.

Mol Genet Metab Rep. 2016 Dec 10;10:11-17. eCollection 2017 Mar.

38.

Upfront autologous stem cell transplantation for newly diagnosed elderly multiple myeloma patients: a prospective multicenter study.

Garderet L, Beohou E, Caillot D, Stoppa AM, Touzeau C, Chretien ML, Karlin L, Moreau P, Fontan J, Blaise D, Polge E, Gueye MS, Ikhlef S, Marjanovic Z, Labopin M, Mohty M.

Haematologica. 2016 Nov;101(11):1390-1397. Epub 2016 Sep 9.

39.

Impact of pharmaceutical intervention on quality of life and coping strategies in patients with haematological malignancies.

Opsomer MA, Anota A, Noblot-Rossignol M, Bonnetain F, Pernot C, Chretien ML, Legouge C, Caillot D, Boulin M.

Ann Pharm Fr. 2016 Nov;74(6):439-447. doi: 10.1016/j.pharma.2016.03.007. Epub 2016 May 6.

PMID:
27162122
40.

H.E.S.S. Limits on Linelike Dark Matter Signatures in the 100 GeV to 2 TeV Energy Range Close to the Galactic Center.

Abdalla H, Abramowski A, Aharonian F, Ait Benkhali F, Akhperjanian AG, Andersson T, Angüner EO, Arrieta M, Aubert P, Backes M, Balzer A, Barnard M, Becherini Y, Becker Tjus J, Berge D, Bernhard S, Bernlöhr K, Birsin E, Blackwell R, Böttcher M, Boisson C, Bolmont J, Bordas P, Bregeon J, Brun F, Brun P, Bryan M, Bulik T, Capasso M, Carr J, Casanova S, Chakraborty N, Chalme-Calvet R, Chaves RC, Chen A, Chevalier J, Chrétien M, Colafrancesco S, Cologna G, Condon B, Conrad J, Couturier C, Cui Y, Davids ID, Degrange B, Deil C, Devin J, deWilt P, Djannati-Ataï A, Domainko W, Donath A, Drury LO, Dubus G, Dutson K, Dyks J, Dyrda M, Edwards T, Egberts K, Eger P, Ernenwein JP, Eschbach S, Farnier C, Fegan S, Fernandes MV, Fiasson A, Fontaine G, Förster A, Funk S, Füßling M, Gabici S, Gajdus M, Gallant YA, Garrigoux T, Giavitto G, Giebels B, Glicenstein JF, Gottschall D, Goyal A, Grondin MH, Grudzińska M, Hadasch D, Hahn J, Hawkes J, Heinzelmann G, Henri G, Hermann G, Hervet O, Hillert A, Hinton JA, Hofmann W, Hoischen C, Holler M, Horns D, Ivascenko A, Jacholkowska A, Jamrozy M, Janiak M, Jankowsky D, Jankowsky F, Jingo M, Jogler T, Jouvin L, Jung-Richardt I, Kastendieck MA, Katarzyński K, Katz U, Kerszberg D, Khélifi B, Kieffer M, King J, Klepser S, Klochkov D, Kluźniak W, Kolitzus D, Komin N, Kosack K, Krakau S, Kraus M, Krayzel F, Krüger PP, Laffon H, Lamanna G, Lau J, Lees JP, Lefaucheur J, Lefranc V, Lemière A, Lemoine-Goumard M, Lenain JP, Leser E, Liu R, Lohse T, Lorentz M, Lypova I, Marandon V, Marcowith A, Mariaud C, Marx R, Maurin G, Maxted N, Mayer M, Meintjes PJ, Meyer M, Mitchell AM, Moderski R, Mohamed M, Morå K, Moulin E, Murach T, de Naurois M, Niederwanger F, Niemiec J, Oakes L, O'Brien P, Odaka H, Ohm S, Ostrowski M, Öttl S, Oya I, Padovani M, Panter M, Parsons RD, Paz Arribas M, Pekeur NW, Pelletier G, Perennes C, Petrucci PO, Peyaud B, Pita S, Poon H, Prokhorov D, Prokoph H, Pühlhofer G, Punch M, Quirrenbach A, Raab S, Reimer A, Reimer O, Renaud M, de Los Reyes R, Rieger F, Romoli C, Rosier-Lees S, Rowell G, Rudak B, Rulten CB, Sahakian V, Salek D, Sanchez DA, Santangelo A, Sasaki M, Schlickeiser R, Schüssler F, Schulz A, Schwanke U, Schwemmer S, Settimo M, Seyffert AS, Shafi N, Shilon I, Simoni R, Sol H, Spanier F, Spengler G, Spies F, Stawarz Ł, Steenkamp R, Stegmann C, Stinzing F, Stycz K, Sushch I, Tavernet JP, Tavernier T, Taylor AM, Terrier R, Tibaldo L, Tluczykont M, Trichard C, Tuffs R, van der Walt J, van Eldik C, van Soelen B, Vasileiadis G, Veh J, Venter C, Viana A, Vincent P, Vink J, Voisin F, Völk HJ, Vuillaume T, Wadiasingh Z, Wagner SJ, Wagner P, Wagner RM, White R, Wierzcholska A, Willmann P, Wörnlein A, Wouters D, Yang R, Zabalza V, Zaborov D, Zacharias M, Zdziarski AA, Zech A, Zefi F, Ziegler A, Żywucka N; H.E.S.S. Collaboration.

Phys Rev Lett. 2016 Oct 7;117(15):151302. Epub 2016 Oct 7.

PMID:
27768338
41.

Serum free light chains, not urine specimens, should be used to evaluate response in light-chain multiple myeloma.

Dejoie T, Corre J, Caillon H, Hulin C, Perrot A, Caillot D, Boyle E, Chretien ML, Fontan J, Belhadj K, Brechignac S, Decaux O, Voillat L, Rodon P, Fitoussi O, Araujo C, Benboubker L, Fontan C, Tiab M, Godmer P, Luycx O, Allangba O, Pignon JM, Fuzibet JG, Legros L, Stoppa AM, Dib M, Pegourie B, Orsini-Piocelle F, Karlin L, Arnulf B, Roussel M, Garderet L, Mohty M, Meuleman N, Doyen C, Lenain P, Macro M, Leleu X, Facon T, Moreau P, Attal M, Avet-Loiseau H.

Blood. 2016 Dec 22;128(25):2941-2948. doi: 10.1182/blood-2016-07-726778. Epub 2016 Oct 11.

42.

Search for Dark Matter Annihilations towards the Inner Galactic Halo from 10 Years of Observations with H.E.S.S.

Abdallah H, Abramowski A, Aharonian F, Ait Benkhali F, Akhperjanian AG, Angüner E, Arrieta M, Aubert P, Backes M, Balzer A, Barnard M, Becherini Y, Becker Tjus J, Berge D, Bernhard S, Bernlöhr K, Birsin E, Blackwell R, Böttcher M, Boisson C, Bolmont J, Bordas P, Bregeon J, Brun F, Brun P, Bryan M, Bulik T, Capasso M, Carr J, Casanova S, Chakraborty N, Chalme-Calvet R, Chaves RC, Chen A, Chevalier J, Chrétien M, Colafrancesco S, Cologna G, Condon B, Conrad J, Couturier C, Cui Y, Davids ID, Degrange B, Deil C, deWilt P, Djannati-Ataï A, Domainko W, Donath A, Drury LO, Dubus G, Dutson K, Dyks J, Dyrda M, Edwards T, Egberts K, Eger P, Ernenwein JP, Eschbach S, Farnier C, Fegan S, Fernandes MV, Fiasson A, Fontaine G, Förster A, Funk S, Füßling M, Gabici S, Gajdus M, Gallant YA, Garrigoux T, Giavitto G, Giebels B, Glicenstein JF, Gottschall D, Goyal A, Grondin MH, Grudzińska M, Hadasch D, Hahn J, Hawkes J, Heinzelmann G, Henri G, Hermann G, Hervet O, Hillert A, Hinton JA, Hofmann W, Hoischen C, Holler M, Horns D, Ivascenko A, Jacholkowska A, Jamrozy M, Janiak M, Jankowsky D, Jankowsky F, Jingo M, Jogler T, Jouvin L, Jung-Richardt I, Kastendieck MA, Katarzyński K, Katz U, Kerszberg D, Khélifi B, Kieffer M, King J, Klepser S, Klochkov D, Kluźniak W, Kolitzus D, Komin N, Kosack K, Krakau S, Kraus M, Krayzel F, Krüger PP, Laffon H, Lamanna G, Lau J, Lees JP, Lefaucheur J, Lefranc V, Lemière A, Lemoine-Goumard M, Lenain JP, Leser E, Lohse T, Lorentz M, Lui R, Lypova I, Marandon V, Marcowith A, Mariaud C, Marx R, Maurin G, Maxted N, Mayer M, Meintjes PJ, Menzler U, Meyer M, Mitchell AM, Moderski R, Mohamed M, Morå K, Moulin E, Murach T, de Naurois M, Niederwanger F, Niemiec J, Oakes L, Odaka H, Ohm S, Öttl S, Ostrowski M, Oya I, Padovani M, Panter M, Parsons RD, Paz Arribas M, Pekeur NW, Pelletier G, Petrucci PO, Peyaud B, Pita S, Poon H, Prokhorov D, Prokoph H, Pühlhofer G, Punch M, Quirrenbach A, Raab S, Reimer A, Reimer O, Renaud M, de Los Reyes R, Rieger F, Romoli C, Rosier-Lees S, Rowell G, Rudak B, Rulten CB, Sahakian V, Salek D, Sanchez DA, Santangelo A, Sasaki M, Schlickeiser R, Schüssler F, Schulz A, Schwanke U, Schwemmer S, Seyffert AS, Shafi N, Simoni R, Sol H, Spanier F, Spengler G, Spieß F, Stawarz L, Steenkamp R, Stegmann C, Stinzing F, Stycz K, Sushch I, Tavernet JP, Tavernier T, Taylor AM, Terrier R, Tluczykont M, Trichard C, Tuffs R, van der Walt J, van Eldik C, van Soelen B, Vasileiadis G, Veh J, Venter C, Viana A, Vincent P, Vink J, Voisin F, Völk HJ, Vuillaume T, Wadiasingh Z, Wagner SJ, Wagner P, Wagner RM, White R, Wierzcholska A, Willmann P, Wörnlein A, Wouters D, Yang R, Zabalza V, Zaborov D, Zacharias M, Zdziarski AA, Zech A, Zefi F, Ziegler A, Żywucka N; H.E.S.S. Collaboration.

Phys Rev Lett. 2016 Sep 9;117(11):111301. doi: 10.1103/PhysRevLett.117.111301. Epub 2016 Sep 8.

PMID:
27661677
43.

CD45 phosphatase is crucial for human and murine acute myeloid leukemia maintenance through its localization in lipid rafts.

Saint-Paul L, Nguyen CH, Buffière A, Pais de Barros JP, Hammann A, Landras-Guetta C, Filomenko R, Chrétien ML, Johnson P, Bastie JN, Delva L, Quéré R.

Oncotarget. 2016 Oct 4;7(40):64785-64797. doi: 10.18632/oncotarget.11622.

44.

Outbreak of Extended-Spectrum Beta-Lactamase Producing Enterobacter cloacae with High MICs of Quaternary Ammonium Compounds in a Hematology Ward Associated with Contaminated Sinks.

Chapuis A, Amoureux L, Bador J, Gavalas A, Siebor E, Chrétien ML, Caillot D, Janin M, de Curraize C, Neuwirth C.

Front Microbiol. 2016 Jul 12;7:1070. doi: 10.3389/fmicb.2016.01070. eCollection 2016.

45.

Prophylactic Efficacy of Quercetin 3-β-O-d-Glucoside against Ebola Virus Infection.

Qiu X, Kroeker A, He S, Kozak R, Audet J, Mbikay M, Chrétien M.

Antimicrob Agents Chemother. 2016 Aug 22;60(9):5182-8. doi: 10.1128/AAC.00307-16. Print 2016 Sep.

46.

Trim33/Tif1γ is involved in late stages of granulomonopoiesis in mice.

Chrétien ML, Legouge C, Martin RZ, Hammann A, Trad M, Aucagne R, Largeot A, Bastie JN, Delva L, Quéré R.

Exp Hematol. 2016 Aug;44(8):727-739.e6. doi: 10.1016/j.exphem.2016.04.009. Epub 2016 Apr 27.

PMID:
27130375
47.

Bortezomib, Doxorubicin, Cyclophosphamide, Dexamethasone Induction Followed by Stem Cell Transplantation for Primary Plasma Cell Leukemia: A Prospective Phase II Study of the Intergroupe Francophone du Myélome.

Royer B, Minvielle S, Diouf M, Roussel M, Karlin L, Hulin C, Arnulf B, Macro M, Cailleres S, Brion A, Brechignac S, Belhadj K, Chretien ML, Wetterwald M, Chaleteix C, Tiab M, Leleu X, Frenzel L, Garderet L, Choquet S, Fuzibet JG, Dauriac C, Forneker LM, Benboubker L, Facon T, Moreau P, Avet-Loiseau H, Marolleau JP.

J Clin Oncol. 2016 Jun 20;34(18):2125-32. doi: 10.1200/JCO.2015.63.1929. Epub 2016 Apr 25.

PMID:
27114594
48.

Autologous stem cell transplantation for patients aged 60 years or older with refractory or relapsed classical Hodgkin's lymphoma: a retrospective analysis from the French Society of Bone Marrow Transplantation and Cell Therapies (SFGM-TC).

Stamatoullas A, Brice P, Gueye MS, Mareschal S, Chevallier P, Bouabdallah R, Nguyenquoc S, Francois S, Turlure P, Ceballos P, Monjanel H, Bourhis JH, Guillerm G, Mohty M, Biron P, Cornillon J, Belhadj K, Bonmati C, Dilhuydy MS, Huynh A, Bernard M, Chrétien ML, Peffault de Latour R, Tilly H.

Bone Marrow Transplant. 2016 Jul;51(7):928-32. doi: 10.1038/bmt.2016.76. Epub 2016 Apr 4.

PMID:
27042842
49.

Evolution of procalcitonin, C-reactive protein and fibrinogen levels in neutropenic leukaemia patients with invasive pulmonary aspergillosis or mucormycosis.

Roques M, Chretien ML, Favennec C, Lafon I, Ferrant E, Legouge C, Plocque A, Golfier C, Duvillard L, Amoureux L, Bastie JN, Maurin-Bernier L, Dalle F, Caillot D.

Mycoses. 2016 Jun;59(6):383-90. doi: 10.1111/myc.12487. Epub 2016 Mar 2.

PMID:
26931315
50.

Emergency and elective pulmonary surgical resection in haematological patients with invasive fungal infections: a report of 50 cases in a single centre.

Chretien ML, Legouge C, Pagès PB, Lafon I, Ferrant E, Plocque A, Favennec C, Estivalet L, Bottolier-Lemallaz E, Dalle F, Bastie JN, Bernard A, Caillot D.

Clin Microbiol Infect. 2016 Sep;22(9):782-787. doi: 10.1016/j.cmi.2015.12.029. Epub 2016 Jan 22.

Supplemental Content

Loading ...
Support Center